Tiered Lyme testing
Detailed band analysis
Expert clinical correlation
Lyme disease is one of the most commonly missed and misunderstood chronic infections. Many patients are told they’re negative based on incomplete screening.
The panel begins with a comprehensive Lyme antibody screen, measuring IgM and IgG antibodies to Borrelia burgdorferi to detect immune response. If the screen is positive or borderline, the test automatically reflexes to a detailed Western Blot confirmation, including multiple IgM bands for acute infection and IgG bands for chronic or past exposure. Band-specific analysis allows clinicians to confirm true exposure, differentiate early versus chronic infection, avoid false positives, and correlate lab findings with your symptom patterns.
Most Lyme testing stops at a basic antibody screen, relies on narrow CDC criteria, misses chronic or immune-evasive infections, and can give false reassurance. This panel provides tiered testing with automatic reflex to Western Blot, detailed IgM/IgG band analysis, expert clinical correlation, and clarity when symptoms do not match standard “negative” labs. This is diagnostic precision—not dismissal.
No. Some early or immune-evasive infections may not be detected on standard testing. This panel is designed to reduce false negatives.
It uses layered, reflex testing, including full Western Blot band analysis, rather than stopping at a basic antibody screen.
Yes. Detailed IgG band interpretation helps identify chronic or past exposure that standard screening may miss.
Yes, for antibody and Western Blot testing. Phlebotomy is coordinated by the clinic.
